| 双语新闻 Bilingual News | 双语对照阅读 分级系列阅读 智能辅助阅读 在线英语学习 |
|
| 双语新闻 Bilingual News | 双语对照阅读 分级系列阅读 智能辅助阅读 在线英语学习 |
| [英文] [中文] [双语对照] [双语交替] [] |
| The chairman of the Chinese drugmaker Sinovac said China had approved the company’s Covid-19 vaccine for children as young as 3, which would make the country the first in the world to endorse a shot for such young children. |
| The World Health Organization has cleared both Sinovac’s vaccine and one made by another Chinese company, Sinopharm, for emergency use in adults 18 and older. China has kept the coronavirus largely under control in recent months, and schools there have remained open. But in other countries, the availability of effective vaccines for children and adolescents will be crucial for allowing schools to operate more safely. |
| The United States has authorized the Pfizer-BioNTech vaccine for people 12 and older. Pfizer expects to submit its vaccine for authorization for children as young as 2 in September, the company said during an earnings call last month. Moderna said last month that its vaccine was highly effective in 12- to 17-year-olds, though regulators have not yet endorsed the company’s shot for that age group. |
| In an interview with the state broadcaster China Central Television, Sinovac’s chairman, Yin Weidong, said the company’s clinical trials involving “hundreds” of people had found that its vaccine was just as safe and effective in people ages 3 to 17 as it was in adults. |
| After Sinovac reported these results to Chinese regulators, they approved the shot for use in the younger age group, Mr. Yin said. He said the government would ultimately decide when vaccines might start being administered to children. |
| CCTV cited an unnamed government official who confirmed that the authorities had endorsed the use of Covid vaccines in people as young as 3. Regulators have not officially announced the approval, however. |
OK阅读网 版权所有(C)2017 | 联系我们